Compass Biotechnologies Inc (COBI) 0.0002 $COBI
Compass Biotechnologies Appoints Interim President
ACCESSWIRE - Mon Mar 28, 12:31PM CDT
SALT LAKE CITY, UT / ACCESSWIRE / March 28, 2016 / Compass Biotechnologies Inc. (OTC PINK: COBI) (PINKSHEETS: COBI) (Compass) Compass Biotechnologies Inc.
Equity Market Movement at a Glance -- Analyst Research on Compass Biotechnologies, Liquidmetal Technologies, Otsuka Holdings and Enel
ACCESSWIRE - Thu Mar 10, 9:15AM CST
NEW YORK, NY / ACCESSWIRE / March 10, 2016 / Moments ago, Trader's Choice released new research updates concerning several important developing situations including the following equities: Compass Biotechnologies Inc. (OTC: COBI), Liquidmetal Technologies Inc. (OTC: LQMT), Otsuka Holdings Co. Ltd. (OTC: OTSKY) and Enel SpA (OTC: ENLAY). Trader's Choice has perfected the profitable art of picking stocks, cutting through the noise to deliver the top trade, every year. The full Research Packages are being made available to the public on a complimentary basis.
Compass Biotechnologies Inc. Announces Immanent Acquisition and Management Change
ACCESSWIRE - Tue Mar 08, 7:30AM CST
SALT LAKE CITY UT / ACCESSWIRE / March 8, 2016 / Compass Biotechnologies Inc. (OTC PINK: COBI) (PINKSHEETS: COBI) (Compass) Compass Biotechnologies Inc.
Compass Biotechnologies Inc. Announces Acquisition of efsAUDIO Inc.
ACCESSWIRE - Fri Feb 05, 7:30AM CST
SALT LAKE CITY, UT / ACCESSWIRE / February 5, 2016 / Compass Biotechnologies Inc. (OTC PINK: COBI) (PINKSHEETS: COBI) (Compass) is pleased to announce the previously mentioned acquisition target is efsAUDIO Inc., manufacturer of the Motion Sound product line. Since 1994, Motion Sound products have been developed and manufactured with the focus on innovation, quality, reliability and tone. Motion Sound amplifiers are recognized as an industry standard through their quality and innovation in proprietary rotary speaker technology and stereo amplification for organs, pianos and synthesizers. Motion Sound keyboard and guitar amplifiers are used and endorsed by well-known artists throughout the world. To view a list of artists, please visit the Motion Sound web site at www.msamps.com.
Compass Biotechnologies to Decrease Authorized Share Limit and General Update
ACCESSWIRE - Mon Dec 21, 8:01AM CST
SALT LAKE CITY, UT / ACCESSWIRE / December 21, 2015 / Compass Biotechnologies Inc. (OTC PINK: COBI) (PINKSHEETS: COBI) (Compass) Compass Biotechnologies is pleased to announce that the Company recently updated its financial statements and disclosures and is now OTC Pink Current Information status. The strategic move intended to boost shareholder value, prior to the forthcoming acquisition, will result in the Company reducing the authorized capital share amount to a total of One Billion Shares. "As the discussions continue with our acquisition target, management believes this will be in the Company and its Shareholders best interests to reduce the authorized capital share limit prior to finalizing the definitive terms of the acquisition," remarked Richard Shykora, Interim CEO of Compass. The necessary amendments to be filed with the Secretary of State of Nevada are completed and have been filed and we will await the effectiveness confirmation from the Nevada SOS.
Compass Biotechnologies Appoints Interim President
ACCESSWIRE - Mon Mar 28, 12:31PM CDT
SALT LAKE CITY, UT / ACCESSWIRE / March 28, 2016 / Compass Biotechnologies Inc. (OTC PINK: COBI) (PINKSHEETS: COBI) (Compass) Compass Biotechnologies Inc.
Equity Market Movement at a Glance -- Analyst Research on Compass Biotechnologies, Liquidmetal Technologies, Otsuka Holdings and Enel
ACCESSWIRE - Thu Mar 10, 9:15AM CST
NEW YORK, NY / ACCESSWIRE / March 10, 2016 / Moments ago, Trader's Choice released new research updates concerning several important developing situations including the following equities: Compass Biotechnologies Inc. (OTC: COBI), Liquidmetal Technologies Inc. (OTC: LQMT), Otsuka Holdings Co. Ltd. (OTC: OTSKY) and Enel SpA (OTC: ENLAY). Trader's Choice has perfected the profitable art of picking stocks, cutting through the noise to deliver the top trade, every year. The full Research Packages are being made available to the public on a complimentary basis.
Compass Biotechnologies Inc. Announces Immanent Acquisition and Management Change
ACCESSWIRE - Tue Mar 08, 7:30AM CST
SALT LAKE CITY UT / ACCESSWIRE / March 8, 2016 / Compass Biotechnologies Inc. (OTC PINK: COBI) (PINKSHEETS: COBI) (Compass) Compass Biotechnologies Inc.
Compass Biotechnologies Inc. Announces Acquisition of efsAUDIO Inc.
ACCESSWIRE - Fri Feb 05, 7:30AM CST
SALT LAKE CITY, UT / ACCESSWIRE / February 5, 2016 / Compass Biotechnologies Inc. (OTC PINK: COBI) (PINKSHEETS: COBI) (Compass) is pleased to announce the previously mentioned acquisition target is efsAUDIO Inc., manufacturer of the Motion Sound product line. Since 1994, Motion Sound products have been developed and manufactured with the focus on innovation, quality, reliability and tone. Motion Sound amplifiers are recognized as an industry standard through their quality and innovation in proprietary rotary speaker technology and stereo amplification for organs, pianos and synthesizers. Motion Sound keyboard and guitar amplifiers are used and endorsed by well-known artists throughout the world. To view a list of artists, please visit the Motion Sound web site at www.msamps.com.
Compass Biotechnologies to Decrease Authorized Share Limit and General Update
ACCESSWIRE - Mon Dec 21, 8:01AM CST
SALT LAKE CITY, UT / ACCESSWIRE / December 21, 2015 / Compass Biotechnologies Inc. (OTC PINK: COBI) (PINKSHEETS: COBI) (Compass) Compass Biotechnologies is pleased to announce that the Company recently updated its financial statements and disclosures and is now OTC Pink Current Information status. The strategic move intended to boost shareholder value, prior to the forthcoming acquisition, will result in the Company reducing the authorized capital share amount to a total of One Billion Shares. "As the discussions continue with our acquisition target, management believes this will be in the Company and its Shareholders best interests to reduce the authorized capital share limit prior to finalizing the definitive terms of the acquisition," remarked Richard Shykora, Interim CEO of Compass. The necessary amendments to be filed with the Secretary of State of Nevada are completed and have been filed and we will await the effectiveness confirmation from the Nevada SOS.
